Evaluation of the Efficacy of Intrastromal Antifungal Injection and Prognostic Factors Affecting Treatment Success in Fungal Keratitis

Purpose To assess the clinical outcomes of intrastromal antifungal (ISAF) injection in fungal keratitis and to identify the etiologic and prognostic factors that differentiate responsive from refractory cases.Methods Patients with fungal keratitis treated in a tertiary cornea unit between January 2023 and January 2026 who received ISAF injection after an inadequate response to fortified topical therapy were reviewed retrospectively. Intrastromal voriconazole (50 µg/0.1 mL) was given first; amphotericin B (5 µg/0.1 mL) was added only in eyes that continued to progress. Healing was defined biomicroscopically as epithelial closure, resolution of hypopyon and resolution of the infiltrate.Results Twenty-nine patients (mean age 54.3 ± 22.3 years) were included. Previous ocular surface surgery (n = 13) and trauma (n = 7) predominated; Candida (34.5%) and Fusarium (24.1%) were isolated most often. Twenty eyes (69.0%) responded to ISAF and nine (31.0%) were refractory; mean healing time was 38.8 ± 19.2 days. Cross-linking was performed in five refractory eyes, two of which healed; seven eyes required therapeutic keratoplasty. A longer symptom-to-presentation interval (22.8 vs 6.3 days, p = 0.013) and a lesion larger than 6 mm (p < 0.001) were associated with treatment failure.Conclusion Clinical resolution followed ISAF injection in most refractory eyes, but without a control arm its separate contribution cannot be established. Delayed presentation, larger lesion size and central location were associated with an unfavorable outcome.

Authors

Institutions

Publication Details

Journal
Ocular Immunology and Inflammation
Published
2026-11-12
DOI
https://doi.org/10.1080/09273948.2026.2753530
Primary Topic
Ocular Infections and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Evaluation of the Efficacy of Intrastromal Antifungal Injection and Prognostic Factors Affecting Treatment Success in Fungal Keratitis

Eda Nur Gönültaş Özkan, Mustafa Aksoy, Hafize Gökben Ulutaş, Sami Yılmaz et al.
Ocular Immunology and Inflammation
Ocular Infections and Treatments
article

Evaluation of the Efficacy of Intrastromal Antifungal Injection and Prognostic Factors Affecting Treatment Success in Fungal Keratitis

Eda Nur Gönültaş Özkan, Mustafa Aksoy, Hafize Gökben Ulutaş, Sami Yılmaz, Merve Birge Ergün
article en

Abstract

Purpose To assess the clinical outcomes of intrastromal antifungal (ISAF) injection in fungal keratitis and to identify the etiologic and prognostic factors that differentiate responsive from refractory cases.Methods Patients with fungal keratitis treated in a tertiary cornea unit between January 2023 and January 2026 who received ISAF injection after an inadequate response to fortified topical therapy were reviewed retrospectively. Intrastromal voriconazole (50 µg/0.1 mL) was given first; amphotericin B (5 µg/0.1 mL) was added only in eyes that continued to progress. Healing was defined biomicroscopically as epithelial closure, resolution of hypopyon and resolution of the infiltrate.Results Twenty-nine patients (mean age 54.3 ± 22.3 years) were included. Previous ocular surface surgery (n = 13) and trauma (n = 7) predominated; Candida (34.5%) and Fusarium (24.1%) were isolated most often. Twenty eyes (69.0%) responded to ISAF and nine (31.0%) were refractory; mean healing time was 38.8 ± 19.2 days. Cross-linking was performed in five refractory eyes, two of which healed; seven eyes required therapeutic keratoplasty. A longer symptom-to-presentation interval (22.8 vs 6.3 days, p = 0.013) and a lesion larger than 6 mm (p < 0.001) were associated with treatment failure.Conclusion Clinical resolution followed ISAF injection in most refractory eyes, but without a control arm its separate contribution cannot be established. Delayed presentation, larger lesion size and central location were associated with an unfavorable outcome.

Ocular Immunology and Inflammation
Sağlık Bilimleri Üniversitesi (TR), Bursa City Hospital (TR)
Good health and well-being
Ocular Infections and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon